Literature DB >> 31584148

Esophagitis After Bariatric Surgery: Large Cross-sectional Assessment of an Endoscopic Database.

Reem Matar1, Daniel Maselli1, Eric Vargas1, Jaruvongvanich Veeravich1, Fateh Bazerbachi1, Azizullah Beran1, Andrew C Storm1, Todd Kellogg2, Barham K Abu Dayyeh3.   

Abstract

INTRODUCTION: Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are common bariatric surgeries that can alter physiological barriers against gastroesophageal reflux disease (GERD). We investigated the prevalence and potential physiologic underpinnings of erosive esophagitis (EE) after bariatric surgery in a large cohort with long-term follow-up.
METHODS: This is a retrospective analysis of 517 patients who underwent an esophagogastroduodenoscopy after SG or RYGB. A matched case-control sub-study was conducted to compare physiologic contributors of GERD after SG with a pre-operative cohort using high-resolution manometry.
RESULTS: Consecutive post-SG and post-RYGB patients (body mass index (BMI) 34 ± 9.1 kg/m2, age 49 ± 12.4 years, 83% female) were included. EE was more prevalent after SG than RYGB (37.9% vs. 17.6%, p = 0.0001), including severe EE (10.7% vs. 3.1%, p = 0.0007). Post-SG EE remained more prevalent after adjusting for multiple confounders (OR = 2.47, p = 0.0012). In a matched case-control analysis, prevalence of EE was 31% in 39 SG patients compared with 13% in 40 pre-bariatric surgery patients with GERD and obesity (p = 0.044). Significant physiologic changes conducive to GERD was observed after SG including (1) decrease resting lower esophageal sphincter (LES) (mmHg) pressure (21.3 ± 14.1 vs. 39.8 ± 35.6, p = 0.004), and (2) lower maximal distal contractile integral (DCI) (mmHg-s-cm) (3814.8 ± 2684.8 vs. 5111.8 ± 7713, p = 0.034).
CONCLUSION: EE is more prevalent after SG compared with RYGB in a pre-bariatric surgery cohort with GERD. SG is associated with significant esophageal physiologic changes conducive to GERD and its clinical consequences.

Entities:  

Keywords:  Bariatric surgery; Erosive esophagitis; GERD; Hiatal hernia; PPI; Roux-en-Y gastric bypass; Sleeve gastrectomy

Mesh:

Year:  2020        PMID: 31584148     DOI: 10.1007/s11695-019-04164-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  31 in total

1.  Correlation Between Symptomatic Gastro-Esophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) Post-vertical Sleeve Gastrectomy (VSG).

Authors:  Chin Hong Lim; Phong Ching Lee; Eugene Lim; Jeremy Tan; Weng Hoong Chan; Hong Chang Tan; Sonali Ganguly; Kwang Wei Tham; Alvin Eng
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

2.  Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.

Authors:  Emanuele Soricelli; Giovanni Casella; Giovanni Baglio; Roberta Maselli; Ilaria Ernesti; Alfredo Genco
Journal:  Surg Obes Relat Dis       Date:  2018-02-13       Impact factor: 4.734

3.  Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Yi-Chia Lee; Chi-Yang Chang; Ching-Tai Lee; Jaw-Town Lin
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

4.  Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations.

Authors:  M A van Herwaarden; M Samsom; A J Smout
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

5.  Rates of reflux before and after laparoscopic sleeve gastrectomy for severe obesity.

Authors:  Caroline E Sheppard; Daniel C Sadowski; Christopher J de Gara; Shahzeer Karmali; Daniel W Birch
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

6.  Role of duodenogastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms.

Authors:  Xiao-rong Xu; Zhao-shen Li; Duo-wu Zou; Guo-ming Xu; Ping Ye; Zhen-xing Sun; Qing Wang; Yan-jun Zeng
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

7.  Sleeve gastrectomy and development of "de novo" gastroesophageal reflux.

Authors:  Gianmattia Del Genio; Salvatore Tolone; Paolo Limongelli; Luigi Brusciano; Antonio D'Alessandro; Giovanni Docimo; Gianluca Rossetti; Gianfranco Silecchia; Antonio Iannelli; Alberto del Genio; Federica del Genio; Ludovico Docimo
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

Review 8.  Sleeve gastrectomy and gastroesophageal reflux disease.

Authors:  Michael Laffin; Johnny Chau; Richdeep S Gill; Daniel W Birch; Shahzeer Karmali
Journal:  J Obes       Date:  2013-07-15

9.  Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis.

Authors:  Mei-Juan Li; Qing Li; Min Sun; Li-Qin Liu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

10.  ENDOSCOPIC CHANGES RELATED TO GASTROESOPHAGEAL REFLUX DISEASE: COMPARATIVE STUDY AMONG BARIATRIC SURGERY PATIENTS.

Authors:  Marco Aurelio Santo; Sylvia Regina Quintanilha; Cesar Augusto Mietti; Flavio Masato Kawamoto; Allan Garms Marson; Roberto de Cleva
Journal:  Arq Bras Cir Dig       Date:  2015
View more
  11 in total

Review 1.  Gastroesophageal Reflux After Sleeve Gastrectomy.

Authors:  Francisco A Guzman-Pruneda; Stacy A Brethauer
Journal:  J Gastrointest Surg       Date:  2020-09-15       Impact factor: 3.452

2.  Authors Response from Letter to the Editor Concerning: Bures C, Benzing C, Marchesini JC, Sobottka WH, Sadowski JA, Marchesini JB, Zorron R. The "Hug" Technique Roux-en-Y Gastric Bypass with Preservation of the Posterior Wrap in Patients with Nissen Fundoplication: a Simple Solution for a Complex Problem.

Authors:  João Caetano Marchesini
Journal:  Obes Surg       Date:  2020-10-19       Impact factor: 4.129

3.  Gastroesophageal Reflux Disease, Esophagitis, and Barrett's Esophagus 3 to 4 Years Post Sleeve Gastrectomy.

Authors:  Samer Elkassem
Journal:  Obes Surg       Date:  2021-10-02       Impact factor: 4.129

4.  Clinical Endoscopic and Histologic Findings of a Long-Term Follow-Up (10.7 Years) After Roux-en-Y Laparoscopic Gastric Bypass: a Prospective Study.

Authors:  Attila J Csendes; Deycies L Gaete; Bárbara M Carreño; Benjamín Panza
Journal:  Obes Surg       Date:  2022-07-01       Impact factor: 3.479

5.  Management of gastric intestinal metaplasia in patients undergoing routine endoscopy before bariatric surgery.

Authors:  Yilon Lima Cheng; Enrique F Elli
Journal:  Updates Surg       Date:  2021-09-29

6.  GASTROESOPHAGEAL SYMPTOMS AFTER LAPAROSCOPIC GASTRIC BYPASS: MISTAKES IN PERFORMING THE PROCEDURE?

Authors:  Italo Braghetto; Owen Korn; Luis Gutiérrez; Andrés Torrealba; Jorge Rojas
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

Review 7.  Endoscopic Evaluation and Management of Late Complications After Bariatric Surgery: a Narrative Review.

Authors:  Vivek Kumbhari; Carel W le Roux; Ricardo V Cohen
Journal:  Obes Surg       Date:  2021-07-30       Impact factor: 4.129

8.  The Impact of the Gastric Twist on Esophagitis Progression After Sleeve Gastrectomy: Mid-Term Endoscopic Findings.

Authors:  Álvaro A B Ferraz; José-Tarcísio Dias da Silva; Fernando Santa-Cruz; Maria-Améllia R Aquino; Luciana T Siqueira; Flávio Kreimer
Journal:  Obes Surg       Date:  2020-07-14       Impact factor: 4.129

9.  WHEN SHOULD BE CONVERTED LAPAROSCOPIC SLEEVE GASTRECTOMY TO LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS DUE TO GASTROESOPHAGEAL REFLUX?

Authors:  Italo Braghetto; Owen Korn; Anamaría Burgos; Manuel Figueroa
Journal:  Arq Bras Cir Dig       Date:  2021-01-25

10.  Indications and Outcomes of Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: a Systematic Review and a Meta-analysis.

Authors:  Reem Matar; Nasser Monzer; Veeravich Jaruvongvanich; Rami Abusaleh; Eric J Vargas; Daniel B Maselli; Azizullah Beran; Todd Kellogg; Omar Ghanem; Barham K Abu Dayyeh
Journal:  Obes Surg       Date:  2021-07-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.